401 studies found for:    Open Studies | "Nevus"
Show Display Options
Rank Status Study
21 Not yet recruiting Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: aminolevulinic acid hydrochloride;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis;   Other: questionnaire administration
22 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
23 Unknown  Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Condition: Melanoma
Intervention:
24 Recruiting Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
Conditions: Burn Injury;   Soft Tissue Injury;   Skin Necrosis;   Scars;   Congenital Giant Nevus;   Skin Tumors
Interventions: Other: denovoDerm;   Other: denovoSkin
25 Recruiting Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
Conditions: Gestational Trophoblastic Tumor;   Good Prognosis Metastatic Gestational Trophoblastic Tumor;   Hydatidiform Mole;   Uterine Corpus Choriocarcinoma
Interventions: Drug: Leucovorin Calcium;   Biological: Dactinomycin;   Drug: Methotrexate;   Other: Quality-of-Life Assessment
26 Recruiting Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
Condition: Patients at Risk for Melanoma
Interventions: Drug: N-acetylcysteine;   Other: Placebo arm
27 Recruiting An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
Condition: Basal Cell Carcinoma
Intervention:
28 Unknown  Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
29 Recruiting Erismodegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome;   Recurrent Skin Cancer
Interventions: Drug: buparlisib;   Drug: erismodegib;   Other: laboratory biomarker analysis;   Other: questionnaire administration
30 Unknown  (Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups
Conditions: Insulin Resistance;   Type 2 Diabetes Mellitus;   Cardiovascular Diseases
Intervention:
31 Recruiting Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia
Conditions: Gestational Trophoblastic Disease;   Gestational Trophoblastic Neoplasia;   Gestational Trophoblastic Tumor;   Gestational Trophoblastic Neoplasms
Interventions: Drug: MTX 1;   Drug: MTX 2;   Biological: Act-d
32 Recruiting Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease
Condition: Trophoblastic Neoplasms
Interventions: Drug: chemotherapy agents;   Procedure: suction curettage
33 Not yet recruiting Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib
Condition: Metastatic Melanoma
Interventions: Drug: Nivolumab;   Drug: Trametinib;   Drug: Dabrafenib
34 Recruiting Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
Conditions: Metastatic Melanoma;   Brain Metastases
Interventions: Drug: Ipilimumab;   Procedure: Stereotactic Radiosurgery
35 Recruiting Access Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma
Condition: Melanoma
Interventions: Drug: Trametinib;   Drug: Dabrafenib
36 Not yet recruiting Radiotherapy or Imiquimod in Complex Lentigo Maligna
Condition: Lentigo Maligna
Interventions: Drug: Imiquimod;   Radiation: Radiotherapy
37 Recruiting Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Condition: Metastatic Melanoma
Intervention: Drug: Temozolomide, Decitabine, Panobinostat
38 Recruiting Treatment of Advanced Melanoma With MK-3475 and Peginterferon
Condition: Melanoma
Interventions: Drug: MK-3475;   Drug: Peginterferon alfa-2b
39 Recruiting Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Ocular Melanoma With Extraocular Extension;   Recurrent Uveal Melanoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Vorinostat
40 Unknown  Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors
Conditions: Metastatic Breast Cancer;   Malignant Melanoma;   Renal Cell Cancer;   Gastrointestinal Cancer
Intervention: Procedure: one - three cycles of cell therapy during 4-6 weeks (3-5x10^7 cells/kg will be given through IV systemically

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years